Literature DB >> 12218416

Persistent phosphorylation of synaptic proteins following middle cerebral artery occlusion.

Shohei Matsumoto1, Mehrdad Shamloo, Atsushi Isshiki, Tadeusz Wieloch.   

Abstract

Transient cerebral ischemia following 1 to 2 hours of middle cerebral artery occlusion (MCAO) in the rat leads to infarction, which can be diminished by synaptic transmission modulators, implying aberrant cell signaling in the pathogenetic process. The authors report here changes in the levels of tyrosine phosphorylated proteins (PTyr) and calcium calmodulin kinase II (CaMKII) phosphorylation of Thr 286, in synaptosomal, particulate, and cytosolic fractions of different cortical areas following 1 or 2 hours of MCAO, or 2 hours of MCAO followed by 2 hours of reperfusion. At the end of 2-hour MCAO, PTyr, and in particular the pp180, indicative of NR2A/B subunit, increased in the synaptosomal fraction in less ischemic areas while it decreased in more severe ischemic regions. During reperfusion, phosphorylation increased at least 2-fold in all reperfused areas. During 2 hours of MCAO, the phosphorylation of CaMKII increased 8- to 10-fold in the synaptosomal fraction in all ischemic brain regions. During reperfusion, the phospho-CaMKII levels remained elevated by approximately 300% compared with the contralateral hemisphere (control). There was no increase in phospho-CaMKII in the cytosolic fraction at any time during or following ischemia in any of the brain regions examined. The authors conclude that both tyrosine kinase coupled pathways, as well as CaMKII-mediated cellular processes associated with synaptic activity, are strongly activated during and particularly following MCAO. These results support the hypothesis that aberrant cell signaling may contribute to ischemic cell death and dysfunction, and that selective modulators of cell signaling may be targets for pharmacological intervention against ischemic brain damage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12218416     DOI: 10.1097/00004647-200209000-00008

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  8 in total

Review 1.  The Functional and Molecular Properties, Physiological Functions, and Pathophysiological Roles of GluN2A in the Central Nervous System.

Authors:  Yongjun Sun; Xiaokun Cheng; Linan Zhang; Jie Hu; You Chen; Liying Zhan; Zibin Gao
Journal:  Mol Neurobiol       Date:  2016-01-21       Impact factor: 5.590

2.  Sinomenine protects against ischaemic brain injury: involvement of co-inhibition of acid-sensing ion channel 1a and L-type calcium channels.

Authors:  Wen-Ning Wu; Peng-Fei Wu; Xiang-Long Chen; Zui Zhang; Jun Gu; Yuan-Jian Yang; Qiu-Ju Xiong; Lan Ni; Fang Wang; Jian-Guo Chen
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

3.  Isoflurane inhibits protein kinase Cgamma and calcium/calmodulin dependent protein kinase ii-alpha translocation to synaptic membranes in ischemic mice brains.

Authors:  Shohei Matsumoto; Michihiro Murozono; Daisuke Nagaoka; Shuhei Matsuoka; Akiko Takeda; Hideyuki Narita; Seigo Watanabe; Atsushi Isshiki; Yasuo Watanabe
Journal:  Neurochem Res       Date:  2008-05-13       Impact factor: 3.996

4.  Expression and function of striatal enriched protein tyrosine phosphatase is profoundly altered in cerebral ischemia.

Authors:  Steven P Braithwaite; Jian Xu; John Leung; Roman Urfer; Karoly Nikolich; Donna Oksenberg; Paul J Lombroso; Mehrdad Shamloo
Journal:  Eur J Neurosci       Date:  2008-05       Impact factor: 3.386

5.  Importance of ERK1/2 in upregulation of endothelin type B receptors in cerebral arteries.

Authors:  Marie Henriksson; Cang-Bao Xu; Lars Edvinsson
Journal:  Br J Pharmacol       Date:  2004-07-05       Impact factor: 8.739

6.  The Role of Striatal-Enriched Protein Tyrosine Phosphatase (STEP) in Cognition.

Authors:  Christopher James Fitzpatrick; Paul J Lombroso
Journal:  Front Neuroanat       Date:  2011-07-29       Impact factor: 3.856

Review 7.  Role of Ca2+/Calmodulin-Dependent Protein Kinase Type II in Mediating Function and Dysfunction at Glutamatergic Synapses.

Authors:  Archana G Mohanan; Sowmya Gunasekaran; Reena Sarah Jacob; R V Omkumar
Journal:  Front Mol Neurosci       Date:  2022-06-20       Impact factor: 6.261

Review 8.  Calcium/Calmodulin-Dependent Protein Kinase II in Cerebrovascular Diseases.

Authors:  Xuejing Zhang; Jaclyn Connelly; Edwin S Levitan; Dandan Sun; Jane Q Wang
Journal:  Transl Stroke Res       Date:  2021-03-13       Impact factor: 6.829

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.